Mustafa Solak
- 4.6 優秀 • 218 レビュー
- 20年の経験
- トルコ, イスタンブール, Hisar Hospital Intercontinental
Solak医師は肺癌の放射線治療を専門とし、Hacettepe大学癌研究所およびMDアンダーソン癌センターで研鑽を積みました。
- Hacettepe大学癌研究所にてフェローシップを修了
- テキサス大学MDアンダーソン癌センターに勤務
- 肺癌をはじめとする各種悪性腫瘍を担当
- Hacettepe大学医学部を卒業
- 続きを読む
Solak医師は肺癌の放射線治療を専門とし、Hacettepe大学癌研究所およびMDアンダーソン癌センターで研鑽を積みました。
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
オフェル・メリムスキー教授は、骨腫瘍・軟部腫瘍・中皮腫・肺癌・肝臓および肺への転移性病変を専門とする著名な腫瘍内科医です。スラスキー医療センター(イヒロフ、テルアビブ)の骨格・軟部腫瘍科の科長を務め、イスラエル臨床腫瘍医協会の会長を兼任しています。
主な専門領域と患者様へのメリット:
患者様はメリムスキー教授の深い腫瘍学的知識、個別化された治療計画の立案能力、そして細やかな対応を高く評価しており、治療の全過程を通じて安心感と信頼感が得られると好評です。
Personal information
Title: Professor Doctor
Branch: Radiation Oncology
Work History:
1 GATA Military Medical Faculty
2 Gayrettepe Florence Nightingale Hospital
3 T.R. Demiroğlu Bilim University \ Associate Professor
4 T.R Demiroğlu Bilim University \ Professor
Medical Specialties and Subspecialties:
1 Head and Neck Cancers
2 Radiation Oncology
Priority treatments:
1 Prostate cancer
2 Conformal treatments
Special advanced health technologies:
1 Truebeam Stx Technology
2 Halcyons
Education
1991 - Istanbul University Istanbul Faculty of Medicine
1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation
Oncology Specialization Training
Professional experience:
04.2009 – 04.2013: Resident in the Department for Radiation Oncology, Klinikum Offenbach
05.2013 – 12. 2015: Senior physician in the Department for Radiation Oncology, Klinikum Offenbach
Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.
He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.
アリ・ラファエル教授――テルアビブ・スラスキー医療センター(イキロフ、テルアビブ)トランスレーショナル腫瘍学部門長および臨床がん研究部門研究員。患者一人ひとりのニーズに寄り添う個別対応のアプローチが高く評価されています。
資格および患者への貢献:
腫瘍科デイホスピタルを統括し、国家ゲノム医療プロジェクトを主導。最先端の研究へのアクセスを提供しています。
主任副研究者および主任研究者として、腫瘍内mRNA投与やウイルス製剤を含むフェーズI〜IIIの多数の臨床試験に携わってきました。患者は革新的な治療法への参加機会を得られます。
米国および英国における国際的な臨床経験を有し、世界水準の治療基準と先進的なプロトコルの適用を保証しています。
国際学術団体の会員(ESMO、IASLC、ISLB、ISCORT、Israeli Medical Association)。最新の治療基準を活用し、国際的な研究に参画しています。
ICH GCP R2、Israeli MOH Guidelinesをはじめ、インフォームドコンセント、副作用管理および患者安全に関する最新課程を含む国際臨床実践基準に基づき、定期的に専門知識の更新および研修を実施しています。
ラファエル教授は、精密な治療レジメンの選択、革新的手法の導入、そして細やかな患者対応により高い信頼を得ており、治療のすべての段階において患者が安心して療養に臨める環境を提供しています。
Dr. Verges graduated in Medicine and Surgery from the University of Barcelona in 1980 and moved to Boston (USA) to conduct basic research in ophthalmology, obtaining a PhD in Biology from Harvard University and defending his doctoral thesis on the mechanisms of tear secretion, which would become the basis for understanding the pathology of dry eye syndrome (thesis presented in Barcelona, 1983) and which earned him the National Research Prize (1983).
Currently, Dr. Carlos Verges carries out his professional activity as the Director of the Ophthalmology Service of the Dexéus University Hospital, together with his entire medical team from the advanced ophthalmology department, where he has a high-quality technological, medical and surgical team.
His area of interest is focused on the field of cataract and neurophysiological mechanisms of vision, especially in relation to sports.
Professional experience
1983-1986 Associate Professor, Department of Ophthalmology, Faculty of Medicine, University of Barcelona, Spain
1986-1989 Head of the Anterior Segment Unit, Department of Ophthalmology, Barcelona Hospital Clinic, Spain.
1986-1991 Professor of Ophthalmology, Faculty of Medicine, University of Barcelona, Spain.
1990-1992 Head of Ophthalmology Service, Hospital del Mar, Barcelona.
1989-1999 Head of the Ophthalmology Department, Sagrada Familia Clinic, Barcelona, Spain.
From 2000 to present, President and CEO of the Dr. Carlos Verges Private Foundation.
2000-2007 Head of the Ophthalmology Department, Institut Universitari Dexeus, Barcelona, Spain.
2007 – present General Director of the “Advanced Ophthalmology Department Dr. Verges”, Barcelona, Spain.
2018-present President and Head of the Department of Ophthalmology. University Hospital Dexeus Quironsalud. Polytechnic University of Catalonia.
Awards :
- National Research Prize 1984. Ministry of Education and Science: "The mechanism of tear secretion. The importance of beta-adrenergic receptors in the lacrimation of the lacrimal glands."
- National Prize for the best doctoral dissertation, Shibre Medal, 1984 "Personal contribution to the study of labial secretion. Determination of beta-adrenergic receptors in tear cells"
- National Pharmaceutical Industry Award 1987: "Treatment of immunological rejection in corneal transplantation using cyclosporine A."
- American Society of Implant Refractive Surgery (ASCRS) Award for the best scientific video presented at the annual conference: "Pseudo-Real Housing". First Prize. Seattle, USA, April 1999.
- Award for the most important technical innovation of 1999 from the Spanish Society.
Implantation-refractive surgery. Speaking at the National Congress held in Madrid 1999.
- 2000 Best Scientific Contribution Award "Laser Non-Penetrating Deep Sclerectomy" presented at the American Academy of Ophthalmology Meeting, AAO - Dallas, USA, October 2000.
- Best Paper Award for “GDx Analysis of Retinal Nerve Fiber Layer Thickness after LASIK” presented at the American Society of Cataract and Refractive Surgery, ASCRS, May 2004, San Diego, USA.
- Finalist for the King Jaume I Prize for Basic Research, 2005, sponsored by the Board of Trustees of the Generalitat of Valencia and the Valencian Foundation for Advanced Research.
- Surgical Technical Video Award: "MICS under Vision ICL, The Hook Technique"
Presented at the IX International Congress of Cataract and Refractive Surgery, May/June 2006, Belo Horizonte, Brazil.
Membership in scientific societies
Member of the Executive Board of the International Society of Refractive Surgery (ISRS) and the American Academy of Ophthalmology (AAO).
Member of the editorial board of Ophthalmology Times. Europe.
Member of the editorial board of Cataract and Refractive Surgery (USA).
Member of the Editorial Board of Cataract and Refractive Surgery Today Europe.
Member of the European Society of Cataract and Refractive Surgery (ESCRS).
Scientific reviewer of the journal: Cornea, Journal of Cataract and Refractive Surgery, American Academy of Ophthalmology, Cataract and Refractive Surgery and Archives of the Spanish Society of Ophthalmology.
Dr. Tamer Atasever is a Nuclear Medicine Specialist with 39 years of experience, speaking English and Turkish. He is a professor in Gazi University and has been a director of the Department of Nuclear Medicine in Ankara Order Laboratory. He is a member of the Turkey Association of Nuclear Medicine and the European Association of Nuclear Medicine.
フォックス・ヴィオラ博士は、BKZゾーリンゲン血液腫瘍科・緩和医療科の主任医師です。同クリニックは、認定された集学的腫瘍センターです。フォックス博士は、ドイツおよびヨーロッパにおける腫瘍性疾患の薬物療法の第一人者であり、15年以上の臨床経験を有しています。
同博士は、ドイツ腫瘍学・血液腫瘍学会(GDHO)、ドイツ医師会、およびアメリカがん研究学会に所属しています。また、分子生物学の研究にも従事しており、その研究成果はがん治療および分子診断の発展に貢献しています。
主な専門領域は、化学療法、免疫療法、分子標的療法、および放射線療法です。フォックス博士は、革新的な治療法と患者への細やかな配慮で知られています。その取り組みにより、高い治癒率を達成し、同僚からの高い評価を得ています。
Dr. Taylan Bükülmez is a radiation oncologist at Istinye University Liv Hospital Bahcesehir in Istanbul. He treats breast, prostate, lung, esophageal, and rectal cancers. He uses advanced radiation therapy methods for his patients.
Dr. Bükülmez received his medical degree from Pamukkale University. He completed his specialization at Akdeniz University. Since 2017, he has led the oncology team at Istinye University Liv Hospital. He is known for his focus on patient recovery and new cancer treatments. He has many years of experience at leading oncology centers in Turkey.
Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.
He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.
Member: Egyptian Cancer Society, ESTRO, ESMO.
Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.
He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.
He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.
Dr. Merdan Fayda is a radiation oncologist with 19 years of experience in radio-oncology. He has studied at the Faculty of Medicine at the University of Istanbul and studied radiosurgery at the University of North Carolina (USA). He conducts 4D-radiotherapy, IMRT, MRI, CT, and PET-CT. He has participated in 16 international conferences, and is a member of 3 organizations.
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 20年の経験 | 肺癌放射線治療 | 肺癌の放射線治療を専門とし、MDアンダーソンなどの一流医療機関で研鑽を積む。最適な治療成績を目指した精密治療に注力している。 | トルコ | から $100 |